Page 286 - IJB-9-5
P. 286

International Journal of Bioprinting                              Blood components for tissue graft bioprinting



            mechanically, piston, or pneumatically driven tools. Once   fusion  in vitro was guided using a 3D-printed polymer
            deposited, their shape is maintained by gelification of the   framework .
                                                                        [9]
            ink/bioink by means of induced physicochemical reactions.   Ink and  bioink formulations are  at the core of these
            There are two modalities, ink vs. bioink, that differ in the   technologies, requiring bioink components to interact
            presence of cells in the extruded biomaterial. Primarily,   in non-trivial ways. Several (bio)printed tissue grafts,
            solvent-based extrusion three-dimensional (3D) printing   such as nerve grafts , blood vessels and vascular
                                                                                 [10]
            entails the building of scaffolds with tailored geometry but   networks , tracheal implants , liver , bone ,
                                                                                                  [13]
                                                                                                           [14]
                                                                      [11]
                                                                                          [12]
            without cells [3–5] . To create living constructs, 3D printing   cartilage , vascular , and parathyroid grafts , have
                                                                                [16]
                                                                      [15]
                                                                                                      [17]
            can be followed by cell seeding. However, depending on   been implanted into animals to study their functionality
            the geometry of the printout, the access of cells to the   (Figure 1). However, the clinical translation of these
            core of the construct can be problematic. In contrast,   products faces notable challenges for several reasons,
            SBE bioprinting uses bioinks (i.e., cell-laden inks), thus   mainly related to predictability. First, due to sub-optimal
            implementing the concurrent biofabrication of the scaffold   experimental models, there is no full understanding of the
            and cellular components for the additive manufacturing of   physiological complexity involved, including the dynamic
            living tissue structures . Composite inks/bioinks can be   integration of multiple components (i.e., biomaterials,
                              [6]
            formulated by adding blood-derived products to printable   different  cell  phenotypes,  and a  large  array  of  signaling
            hydrogels. When platelets are added to the solvent, the   proteins) and their interactions with the host tissue/organ.
            distinction between ink and bioink is blurred, as platelets   Many of the critical mechanisms of tissue repair rely on
            are considered anucleated cells. Although platelets lack   the close interplay between cells and the dynamic tissue
            genomic DNA, they contain various RNA biotypes,    microenvironment through molecular signaling .
                                                                                                     [18]
            including coding mRNAs, and the translational machinery
            needed to translate them into proteins. Thus, just like cells,   Therefore, to fulfill as many requirements as possible
            they can react to environmental stimuli granting biological   regarding the predictability of bioprinted scaffolds, an
            complexity to printable biomaterials . However, platelets   utmost need is the correct functionalization of the bioink
                                         [7]
            lack other cellular attributes, such as growth and replication   with signaling molecules. For example, Sun  et al.
                                                                                                           [19]
            capacities. In the clinical context,  regulatory authorities   bioprinted functionalized scaffolds with transforming
            have classified autologous platelet-rich plasma (PRPs) as   growth  factor  beta  3  (TGF-b3)  and  connective  growth
            “non-standardized medicinal products” instead of advanced   factor (CTGF) mixed with bone marrow stromal cells
            therapies.  Therefore,  printable  biomaterials  loaded  with   (BMSCs) for intervertebral disc (IVD) regeneration.
            platelets would have different regulatory considerations   In another example, a 3D-printed polycaprolactone
            than printable biomaterials loaded with cells.     microchamber was coated with platelet-derived growth
                                                               factors (PDGFs) and bone morphogenetic protein 2
               Bioprinting technologies are used in biomedical   (BMP-2), and spheroids containing adipose stromal cells
            research  for  several  purposes,  such  as  creating  disease   (ASCs) were cultured within the microchambers for
            models , drug screening, basic cell biology, or the creation   dual growth factor delivery in bone regeneration . In
                  [8]
                                                                                                        [20]
            of functional implants with structural organization. Due to   another example, methacrylated hyaluronic acid (MeHA)
            injuries, disease, surgery, and other reasons, a large number   combined  with  collagen  bioink  was  loaded  with  nerve
            of patients with tissue defects need graft implantation.   growth factor (NGF), glial cell-derived neurotrophic factor
            Both SBE approaches, 3D printing and bioprinting, can be   (GDNF), and Schwann cells .
                                                                                     [21]
            explored in therapeutic tissue engineering and regenerative   However, the functionalization of bioinks with single/
            medicine  to  create  mature  competent  tissue  grafts  that   dual growth factors does not approach the immense
            integrate within the host tissue once they are implanted.   complexity of cell communication and competent
            The medical need for tissue grafts is particularly important   tissue biofabrication. Alternatively, biomaterials can be
            when tissue defects exceed a critical size. Scalable methods   functionalized with tailored blood-derived products
            include the development of engineering strategies  and   to transform inert biomaterials into reactive (stimuli-
                                                     [9]
            the creation of microtissue building blocks (with fewer   response) biomaterials, drawing inspiration from
            limitations in nutrient transport) that could fuse to generate   physiological  repair  mechanisms  in  which  hemostasis
            a competent implant, either in vitro or with the use of the   (blood  clot  formation,  fibrin  formation)  is  the  starting
            body as a bioreactor. Other challenges involve reproducing   point, and platelet degranulation and secretome release
            the vasculature and metabolic state of the organ. In one   trigger the regenerative cascade .
                                                                                        [18]
            instance, microtissue building blocks were bioprinted and
            cultured chondrogenically to create a competent tissue   This article describes the different types of blood-derived
            graft, and the process of microtissue maturation and   biomaterials that can be used in solvent-based extrusion


            Volume 9 Issue 5 (2023)                        278                         https://doi.org/10.18063/ijb.762
   281   282   283   284   285   286   287   288   289   290   291